Reckitt Benckiser said it would sell off some of its home-care brands and launch a strategic review of its troubled infant-formula unit Mead Johnson as it seeks to streamline its business with a ...

Consumer goods giant Reckitt Benckiser RKT-0.04%decrease; red down pointing triangle isn’t exactly in limbo, even as it awaits a new chief executive. The maker of Lysol and Clearasil posted ...

Reckitt Benckiser will consider options for its troubled nutrition business and offload a portfolio of homecare brands by the end of 2025, it said on Wednesday, planning to refocus on healthcare ...

While Reckitt Benckiser’s focus on essential consumer products provides some defensive characteristics, its high debt levels and narrower product range add risk should the operating environment worsen ...

Reckitt Benckiser (RBGLY) is weighing new options to advance a sale of its Essential Home unit, home to Air Wick fresheners and Cillit Bang cleaners, after offers fell short of expectations ...

Baby formula sales at Reckitt Benckiser are set to be hit by “significant damage” to a warehouse which was struck by a tornado, the consumer hygiene company has said.

Reckitt Benckiser is recalling 145,000 cans of baby formula for possible cross-contamination with Cronobacter sakazakii. The company's recall was issued out of an abundance of caution.

Reckitt Benckiser is pulling Suboxone tablets, which lost patent protection, from the US market, claiming children can be accidentally harmed, but won't do so for a few months. Meanwhile, Reckitt ...

LightRocket via Getty Images Reckitt Benckiser Group’s $1.4 billion settlement with US authorities last week is another reminder that pharmaceutical companies continue to put profits over patients.

Reckitt Benckiser on Friday said it would pursue all options to have a $60 million verdict overturned in a baby formula case in the United States as it stood by the safety of all its products.

Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight.

British company Reckitt Benckiser has agreed to pay $1.4 billion to resolve all U.S. government investigations and claims in what is the biggest drug industry settlement to date stemming from the ...